Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaxcyte Inc (NQ: PCVX )

45.02 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 45.02
Bid (Size) 44.28 (1)
Ask (Size) 48.98 (1)
Prev. Close 45.02
Today's Range 45.02 - 45.02
52wk Range 16.78 - 47.67
Shares Outstanding 78,980,196
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
Upgrades 
Via Benzinga
Vaxcyte Reports Third Quarter 2022 Financial Results and Provides Business Update
From Vaxcyte, Inc.
Via Globe NewsWire

Performance

YTD
+71.31%
+71.31%
1 Month
+3.23%
+3.23%
3 Month
+72.23%
+72.23%
6 Month
+87.66%
+87.66%
1 Year
+127.26%
+127.26%

More News

Read More
Why Shares of Vaxcyte Rose 110.7% This Week
Via The Motley Fool
Vaxcyte to Present at Upcoming Investor Conferences
From Vaxcyte, Inc.
Via Globe NewsWire
Why Investors Are Suddenly Excited About Vaxcyte
Via MarketBeat
Exposures COVID-19
Vaxcyte Announces Closing of $690 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Vaxcyte, Inc.
Via Globe NewsWire
Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Vaxcyte Announces Pricing of $600 Million Public Offering
From Vaxcyte, Inc.
Via Globe NewsWire
Avis Budget, Scholastic And Other Big Gainers From Monday
Via Benzinga
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
From Vaxcyte, Inc.
Via Globe NewsWire
Dow Rises 1.5%; Nasdaq Jumps Over 100 Points
Via Benzinga
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
Via Benzinga
Vaxcyte Shares Surge As Its Pneumococcal Vaccine On Par With Pfizer's Shot In Study
Via Benzinga
Why Is Tricida (TCDA) Stock Down 90% Today?
Via InvestorPlace
How Is The Market Feeling About Vaxcyte?
Via Benzinga
Why Is Vaxcyte (PCVX) Stock Up 70% Today?
Via InvestorPlace
US Stocks Mixed; Dow Jumps 200 Points
Via Benzinga
Vaxcyte Shares Are Soaring: Here's Why
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Vaxcyte Reports Positive Topline Data from Phase 1/2 Proof-of-Concept Study of its 24-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults Aged 18-64
From Vaxcyte, Inc.
Via Globe NewsWire
Vaxcyte to Host Webcast and Conference Call to Discuss Topline Results from the Phase 1/2 Proof-of-Concept Study of VAX-24 Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults
From Vaxcyte, Inc.
Via Globe NewsWire
Vaxcyte Expands Executive Leadership Team with Key Appointments
From Vaxcyte, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.